Salbutamol /Bromhexine / Menthol
Beta-2 adrenergic agonist (bronchodilator)
What it is used for
Therapeutic use is agent- and indication-specific within the class (Beta-2 adrenergic agonist (bronchodilator)). Use according to culture results, national guidelines (Kenya STG/EML where applicable) and the current product SmPC. Cough expectoration /bronchodilator
Warnings
Paradoxical bronchospasm. Hypokalaemia with high dose/nebs especially with steroids/diuretics/xanthines. CV disease: tachycardia/arrhythmia risk. Thyrotoxicosis caution.
Possible side effects
[Salbutamol] Tachycardia, skeletal muscle cramp, palpitation, headaches, severe emotional disturbances, resistance after prolonged use, acidosis, GI disturbances, hypokaleamia, sweat [Bromhexine] Adverse reactions vary by agent. Counsel on common predictable effects and serious warning symptoms (allergy, severe rash, jaundice, unusual bleeding, severe GI symptoms, neurological changes). Report suspected ADRs via national pharmacovigilance channels. [Menthol] Adverse reactions vary by agent. Counsel on common predictable effects and serious warning symptoms (allergy, severe rash, jaundice, unusual bleeding, severe GI symptoms, neurological changes). Report suspected ADRs via national pharmacovigilance channels.
Storage
Store as labelled. Keep out of reach of children.
No reviewed patient-education article is available. The fields shown are from the currently verified medicine record and unavailable fields are not inferred.